Your browser doesn't support javascript.
loading
Phase I study of cetuximab in combination with 5-fluorouracil, mitomycin C and radiotherapy in patients with locally advanced anal cancer.
Leon, Otilia; Guren, Marianne G; Radu, Calin; Gunnlaugsson, Adalsteinn; Johnsson, Anders.
  • Leon O; Department of Oncology, Skåne University Hospital, Lund, Sweden. Electronic address: otilia.leon@skane.se.
  • Guren MG; Department of Oncology, Oslo University Hospital, Oslo, Norway; K.G.Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway.
  • Radu C; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Gunnlaugsson A; Department of Oncology, Skåne University Hospital, Lund, Sweden.
  • Johnsson A; Department of Oncology, Skåne University Hospital, Lund, Sweden.
Eur J Cancer ; 51(18): 2740-6, 2015 Dec.
Article en En | MEDLINE | ID: mdl-26597443

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias del Ano / Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Mitomicina / Radioterapia de Intensidad Modulada / Quimioradioterapia / Cetuximab / Fluorouracilo Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País como asunto: Europa Idioma: En Año: 2015 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias del Ano / Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Mitomicina / Radioterapia de Intensidad Modulada / Quimioradioterapia / Cetuximab / Fluorouracilo Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País como asunto: Europa Idioma: En Año: 2015 Tipo del documento: Article